Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors

Published:2020-01-31 Issue:10 Volume:28 Page:776-780
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Lu Haiyan,Allende Daniela,Liu Xiuli,Zhang Yaxia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference38 articles.

1. Update on pancreatic endocrine tumors;Frankel;Arch Pathol Lab Med,2006

2. Pancreatic endocrine tumors: recent advances;Jensen;Ann Oncol,1999

3. Pancreatic endocrine tumors;Mansour;J Surg Res,2004

4. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature;Papavramidis;J Am Coll Surg,2005

5. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups;Hochwald;J Clin Oncol,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma;Cancers;2024-05-20

2. Prognostic value of PAX8 in small cell lung cancer;Heliyon;2024-04

3. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid;Scientific Reports;2023-08-09

4. Prognostic Value of Pax8 in Small Cell Lung Cancer;2023

5. A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm;Pathology - Research and Practice;2021-07